Guenther, L. (2020) “Ixekizumab Results in Persistent Clinical Improvement in Moderate-to-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial”, Acta Dermato-Venereologica, 100(1), pp. 1–9. doi: 10.2340/00015555-3353.